Novel COVID-19 Vaccine May Provide Protection for Cancer Patients With B-cell Deficiencies
The peptide-based vaccine induces a T cell-dependent response NEW ORLEANS – CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell...
Home » About the AACR » Newsroom » News Release »
The peptide-based vaccine induces a T cell-dependent response NEW ORLEANS – CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell...
The epigenomic signature is evident prior to CD19-targeted CAR T-cell treatment NEW ORLEANS – Acute lymphoblastic leukemia (ALL) cells...
Latinos are also more likely to be diagnosed with this cancer type NEW ORLEANS – Some Latino children diagnosed...
Lisa M. Coussens, PhD, FAACR, inaugurated as President PHILADELPHIA — The American Association for Cancer Research (AACR) welcomes Lisa...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting for...
NEW ORLEANS – During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income...
NEW ORLEANS – In its first year of implementation, the RACE Act has resulted in increased requirements for more...
NEW ORLEANS – A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent...
An mRNA vaccine was combined with CAR T cells that target tumor cells expressing the CLDN6 antigen NEW ORLEANS...